Robotic-assisted Laparoscopic Nephrectomy with Vein Thrombectomy: Initial Experience and Outcomes from a Single Surgeon

Abstract

This study was designed to explore the safety and feasibility of robotic-assisted laparoscopic nephrectomy with vein thrombectomy (RAL-NVT) for the treatment of renal cell carcinoma (RCC) with venous tumor thrombus (VTT). Clinical data of 6 patients treated with RAL-NVT between July 2016 and November 2017 in our hospital were retrospectively collected and analyzed. There were 5 males and 1 female with their age ranging from 48 years to 68 years. Five renal tumors were right-sided and one left-sided. Three cases fell in level 0 VTT, one in level I and two in level II. Preoperative imaging revealed lymph node involvement in 1 case and distant metastasis in 2 cases. For RCC with level 0 VTT, the renal vein of the affected side was adequately and carefully dissected around the thrombus to the proximity of inferior vena cava (IVC) and was ligated with Hem-o-loks without cross-clamping the IVC. For level I and II VTT, the IVC was crossclamped cephalically and caudally around the tumor thrombus and all tributaries were sequentially blocked to ensure the safe retrieval of VTT. All operations were successfully completed without conversion to open operation. The mean operative time was 150 (115–230) min. Cross-clamping of the IVC happened in 3 cases, and the blocking time was 14, 19 and 20 min, respectively. The mean estimated blood loss during the operation was 400 (200–580) mL. The peritoneal drainage tube was removed 5 to 9 days after the operation, and all patients were postoperatively discharged at 6 to 11 days. Postoperative pathological analysis confirmed that the RCCs were comprised of 4 clear cell RCCs, 1 papillary cell RCC, and 1 medullary cell RCC; 2 cases were Fuhrman grade II, 3 cases grade III, and 1 case undefined grade. No recurrence or progression was observed during the follow-up of 4.2 (3–6) months. We concluded that RAL-NVT is highly challenging but safe and feasible for the treatment of RCC with VTT.

Keywords

robotics / laparoscopy / renal cell carcinoma / venous tumor thrombus / thrombectomy

References

[1] ChenW, ZhengR, ZhangS, et al.. Cancer incidence and mortality in China, 2013. Cancer Lett, 2017, 401: 63-71

[2] AbazaR, ShabsighA, CastleE, et al.. Multiinstitutional experience with robotic nephrectomy with inferior vena cava tumor thrombectomy. J Urol, 2016, 195: 865-871

[3] AgochukwuN, ShuchB. Clinical management of renal cell carcinoma with venous tumor thrombus. World J Urol, 2014, 32(3): 581-589

[4] AbazaR. Initial series of robotic radical nephrectomy with vena caval tumor thrombectomy. Eur Urol, 2011, 59(4): 652-656

[5] AbazaR, EunDD, GallucciM, et al.. Robotic surgery for renal cell carcinoma with vena caval tumor thrombus. Eur Urol Focus, 2016, 2(6): 601-607

[6] WangB, LiH, MaX, et al.. Robot-assisted laparoscopic inferior vena cava thrombectomy: Different Sides Require Different Techniques. Eur Urol, 2016, 69(6): 1112-1119

[7] ChopraS, SimoneG, MetcalfeC, et al.. Robot-assisted level II-III inferior vena cava tumor thrombectomy: step-by-step technique and 1-year outcomes. Eur Urol, 2017, 72(2): 267-274

[8] GillIS, MetcalfeC, AbreuA, et al.. Robotic level III inferior vena cava tumor thrombectomy: Initial series. J Urol, 2015, 194(4): 929-938

[9] EdgeSB, ComptonCC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 2010, 17(6): 1471-1414

[10] BluteML, LeibovichBC, LohseCM, et al.. The Mayo clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int, 2004, 94(1): 33-41

[11] DindoD, DemartinesN, ClavienPA. Classification of surgical complications. Ann Surg, 2004, 240(2): 205-213

[12] RomeroFR, MuntenerM, BaggaHS, et al.. Pure laparoscopic radical nephrectomy with level IIvena caval thrombectomy. Urology, 2006, 68(5): 1112-1114

[13] AbazaR. Robotic surgery and minimally invasive management of renal tumors with vena caval extension. Curr Opin Urol, 2011, 21(2): 104-109

[14] BallMW, GorinMA, JayramG, et al.. Robot-assisted radical nephrectomy with inferior vena cava tumor thrombectomy: technique and initial outcomes. Can J Urol, 2015, 22(1): 7666-7670

[15] TsuiKH, ShvartsO, SmithRB, et al.. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the Revised 1997 TNM staging criteria. J Urol, 2000, 163(4): 1090-1095

[16] BigotP, FardounT, BernhardJC, et al.. Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful. World J Urol, 2014, 32(1): 109-114